Hester Biosciences Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 669.83 million compared to INR 749.44 million a year ago. Revenue was INR 679.73 million compared to INR 793.35 million a year ago. Net income was INR 39.84 million compared to INR 111.86 million a year ago. Basic earnings per share from continuing operations was INR 4.73 compared to INR 14.29 a year ago. Diluted earnings per share from continuing operations was INR 4.73 compared to INR 14.29 a year ago.
For the nine months, sales was INR 2,252.91 million compared to INR 1,987.92 million a year ago. Revenue was INR 2,317.84 million compared to INR 2,107.55 million a year ago. Net income was INR 139.39 million compared to INR 220.96 million a year ago. Basic earnings per share from continuing operations was INR 17.36 compared to INR 26.24 a year ago. Diluted earnings per share from continuing operations was INR 17.36 compared to INR 26.24 a year ago.